日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

scL-2PAM: A Novel Countermeasure That Ameliorates Neuroinflammation and Neuronal Losses in Mice Exposed to an Anticholinesterase Organophosphate

scL-2PAM:一种新型的对抗措施,可减轻暴露于抗胆碱酯酶有机磷酸酯的小鼠的神经炎症和神经元丢失。

Moghe, Manish; Kim, Sang-Soo; Guan, Miaoyin; Rait, Antonina; Pirollo, Kathleen F; Harford, Joe B; Chang, Esther H

TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19

TP53基因疗法作为新冠肺炎患者的潜在治疗方法

Harford, Joe B; Kim, Sang Soo; Pirollo, Kathleen F; Chang, Esther H

Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer

整合基因组和功能性microRNA分析发现miR-30-5p是头颈癌的肿瘤抑制因子和潜在的治疗性纳米药物。

Saleh, Anthony D; Cheng, Hui; Martin, Scott E; Si, Han; Ormanoglu, Pinar; Carlson, Sophie; Clavijo, Paul E; Yang, Xinping; Das, Rita; Cornelius, Shaleeka; Couper, Jamie; Chepeha, Douglas; Danilova, Ludmila; Harris, Thomas M; Prystowsky, Michael B; Childs, Geoffrey J; Smith, Richard V; Robertson, A Gordon; Jones, Steven J M; Cherniack, Andrew D; Kim, Sang S; Rait, Antonina; Pirollo, Kathleen F; Chang, Esther H; Chen, Zhong; Van Waes, Carter

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.

激活 p53 家族成员 TAp63:一种针对 p53 改变肿瘤的新型治疗策略

Gunaratne Preethi H, Pan Yinghong, Rao Abhi K, Lin Chunru, Hernandez-Herrera Anadulce, Liang Ke, Rait Antonina S, Venkatanarayan Avinashnarayan, Benham Ashley L, Rubab Farwah, Kim Sang Soo, Rajapakshe Kimal, Chan Clara K, Mangala Lingegowda S, Lopez-Berestein Gabriel, Sood Anil K, Rowat Amy C, Coarfa Cristian, Pirollo Kathleen F, Flores Elsa R, Chang Esther H

Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study

靶向p53基因纳米复合物联合多西他赛治疗晚期实体瘤的安全性和有效性:一项1b期研究

Pirollo, Kathleen F; Nemunaitis, John; Leung, Po Ki; Nunan, Robert; Adams, Jana; Chang, Esther H

Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine

有效治疗胶质母细胞瘤需要穿过血脑屏障并靶向肿瘤,包括癌症干细胞:纳米医学的希望

Kim, Sang-Soo; Harford, Joe B; Pirollo, Kathleen F; Chang, Esther H

Isolation and Culturing of Glioma Cancer Stem Cells

胶质瘤癌干细胞的分离与培养

Kim, Sang-Soo; Pirollo, Kathleen F; Chang, Esther H

A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival

携带p53基因的纳米颗粒可靶向肿瘤(包括癌症干细胞),增强胶质母细胞瘤对化疗的敏感性,并提高生存率。

Kim, Sang-Soo; Rait, Antonina; Kim, Eric; Pirollo, Kathleen F; Nishida, Maki; Farkas, Natalia; Dagata, John A; Chang, Esther H

The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells

靶向纳米药物的临床应用潜力:递送至癌干细胞样细胞

Kim, Sang-Soo; Rait, Antonina; Rubab, Farwah; Rao, Abhi K; Kiritsy, Michael C; Pirollo, Kathleen F; Wang, Shangzi; Weiner, Louis M; Chang, Esther H

Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors

系统性递送的p53纳米颗粒治疗晚期实体瘤的I期研究

Senzer, Neil; Nemunaitis, John; Nemunaitis, Derek; Bedell, Cynthia; Edelman, Gerald; Barve, Minal; Nunan, Robert; Pirollo, Kathleen F; Rait, Antonina; Chang, Esther H